Medicines and Healthcare Products Regulatory Agency (MHRA)
Purchase of DNA Fragment Size Selection System
This is a contract result notice, not an open opportunity. Details from the official award data.
This sits in the lower-middle of the Laboratory & Precision Equipment band — a mid-scale opportunity. Based on 9,869 valued Laboratory & Precision Equipment tenders in our corpus.
Purchase of DNA Fragment Size Selection System (LAB5061 LU Framework Agreement)
What this notice demands of you
1 named, none in explicit obligation language. Each one is quoted from the notice.
Purchase of DNA Fragment Size Selection System (LAB5061 LU Framework Agreement)
Matched against the notice text, so this is a floor — the tender pack will demand things the notice never mentions. “Says must” means the quoted sentence itself used obligation language; anything ambiguous is left as a mention.
Make the case to bid
Reveal who to approach at Medicines and Healthcare Products Regulatory Agency (MHRA), and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
- OCID
- 6a21cdf2-01fa-478a-9ade-14e04e3f844c
- Stage
- contract · Contract
- Source
- Contracts Finder
- Buyer ref
- CF-1828300D0O000000rwimUAA
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Laboratory & Precision Equipment
Medicines and Healthcare Products Regulatory Agency (MHRA)’s tender network